miRNA: a promising therapeutic target in cancer A Menon, N Abd-Aziz, K Khalid, CL Poh, R Naidu International journal of molecular sciences 23 (19), 11502, 2022 | 94 | 2022 |
Role of microRNAs in antiviral responses to dengue infection RR Wong, N Abd-Aziz, S Affendi, CL Poh Journal of biomedical science 27 (1), 4, 2020 | 74 | 2020 |
Development of microRNAs as potential therapeutics against cancer N Abd-Aziz, NI Kamaruzman, CL Poh Journal of oncology 2020, 2020 | 64 | 2020 |
Development of peptide-based vaccines for cancer N Abd-Aziz, CL Poh Journal of oncology 2022, 2022 | 45 | 2022 |
Development of oncolytic viruses for cancer therapy N Abd-Aziz, CL Poh Translational Research 237, 98-123, 2021 | 44 | 2021 |
Oncogenic signaling in tumorigenesis and applications of siRNA nanotherapeutics in breast cancer NI Kamaruzman, NA Aziz, CL Poh, EH Chowdhury Cancers 11 (5), 632, 2019 | 34 | 2019 |
Bortezomib attenuates HIF-1-but not HIF-2-mediated transcriptional activation N Abd‑Aziz, EJ Stanbridge, N Shafee Oncology letters 10 (4), 2192-2196, 2015 | 28 | 2015 |
Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53 N Abd-Aziz, EJ Stanbridge, N Shafee Journal of General Virology 97 (12), 3174-3182, 2016 | 21 | 2016 |
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway WC Ch’ng, N Abd-Aziz, MH Ong, EJ Stanbridge, N Shafee Cellular Oncology 38, 279-288, 2015 | 20 | 2015 |
Engineered oncolytic adenoviruses: an emerging approach for cancer therapy EW Tan, N Abd-Aziz, CL Poh, KO Tan Pathogens 11 (10), 1146, 2022 | 9 | 2022 |
Recombinant enterovirus 71 viral protein 1 fused to a truncated Newcastle disease virus NP (NPt) carrier protein S Mustafa, N Abd-Aziz, WT Saw, SY Liew, K Yusoff, N Shafee Vaccines 8 (4), 742, 2020 | 5 | 2020 |
Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71) N Abd-Aziz, MF Lee, SK Ong, CL Poh Virology 589, 109941, 2024 | | 2024 |
Oncolytic effect of Newcastle disease virus (NDV) strain AF2240 and V4-UPM on hypoxic and normoxic osteosarcoma cells. NN Kosni, N Abd-Aziz, AR Omar, S Ismail, SL Chia Malaysian Journal of Microbiology 19 (4), 2023 | | 2023 |
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. Pathogens 2022, 11, 1146 EW Tan, N Abd-Aziz, CL Poh, KO Tan s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
ONCOLYTIC ACTIVITY OF NEWCASTLE DISEASE VIRUS STRAIN AF2240 IN HYPOXIC CANCER CELLS NB ABD AZIZ | | 2018 |
Newcastle disease virus degrades HIF-1 alpha through proteasomal pathways N Abd-Aziz, EJ Stanbridge, N Shafee | | 2016 |
Effects of Bortezomib on HIF-1 and HIF-2 Transcriptional Activities N Abd Aziz Universiti Putra Malaysia, 2013 | | 2013 |